Creation of Theravax Inc., a 100 Percent Owned Subsidiary of Viropro Inc., to Develop an HIV Vaccine to Be Tested in Canada
May 25, 2006 11:36 ET
|
Viropro, Inc.
MONTREAL, May 25, 2006 (PRIMEZONE) -- Dr. Jean-Marie Dupuy, President and Chief Executive Officer of Viropro Inc. ("Viropro" or "the company") (OTCBB:VPRO), today announced the creation of Theravax...
Professor Claude Griscelli Appointed to Viropro Board of Directors
May 23, 2006 10:00 ET
|
Viropro, Inc.
MONTREAL, May 23, 2006 (PRIMEZONE) -- Viropro Inc. ("Viropro" or "The Company") (OTCBB:VPRO), a company constantly solidifying its reputation as an international expert in the production and set-up of...
Viropro Inc.: An Emerging Player in the Production and Technology Transfer of Therapeutic Proteins
May 09, 2006 10:00 ET
|
Viropro, Inc.
MONTREAL, May 9, 2006 (PRIMEZONE) -- Viropro Inc. ("Viropro" or "The Company") (OTCBB:VPRO) is rapidly solidifying its reputation as an international expert in the production and set-up of technology...
Viropro Teams Up With Parteurop: A World Renowned Firm Specializing in the Bio-Pharmaceutical Domain
April 20, 2006 10:30 ET
|
Viropro, Inc.
MONTREAL, April 20, 2006 (PRIMEZONE) -- Viropro Inc. ("Viropro" or "The Company") (OTCBB:VPRO) announced today the signing of a contract for collaboration with the French consulting firm Parteurop,...
Viropro Inc. Acquires an Exclusive License for Therapeutic Proteins with Immuno Japan Inc.
April 11, 2006 11:00 ET
|
Viropro, Inc.
MONTREAL, April 11, 2006 (PRIMEZONE) -- Today, Jean-Marie Dupuy, Chief Executive Officer of Viropro Inc., -- "Viropro" or "the company" (OTCBB:VPRO) -- is proud to announce the signing of a new...
Viropro Inc. Files its Annual Financial Statement With the SEC
April 10, 2006 09:00 ET
|
Viropro, Inc.
MONTREAL, April 10, 2006 (PRIMEZONE) -- Viropro Inc. ("Viropro" or "The Company") (OTCBB:VPRO) has filed its annual financial report with the SEC, thereby terminating the temporary change of the...
Viropro Inc. Comments on Ticker Symbol Change
March 20, 2006 09:00 ET
|
Viropro, Inc.
MONTREAL, March 20, 2006 (PRIMEZONE) -- Viropro Inc. ("Viropro" or "The Company") (OTCBB:VPROE) sought to clarify the status of its SEC requisite filings that have been delayed due to recent...
Viropro Inc. Completes a $1,310,000 U.S. Debenture Financing
March 02, 2006 09:00 ET
|
Viropro, Inc.
MONTREAL, March 2, 2006 (PRIMEZONE) -- Dr Jean-Marc Dupuy, Chief Executive Officer of Viropro Inc., "Viropro" or "the company" (OTCBB:VPRO) is pleased to announce that Viropro has concluded a...
Viropro, Inc. Selects HKDP Communications and public affairs
February 22, 2006 09:00 ET
|
Viropro, Inc.
MONTREAL, Feb. 22, 2006 (PRIMEZONE) -- Viropro, Inc. (OTCBB:VPRO) -- an expert in the development and transfer of technologies for biogeneric recombinant products -- is proud to announce that it has...
Viropro Inc. Announces Term Sheet for Financing of up to a Maximum of US $2.8 Million
February 02, 2006 08:00 ET
|
Viropro, Inc.
Objectives of this financing:
-- Attain profitability and revenue objectives for 2006
-- Accelerate business development of Viropro on international
markets
-- Maximize investors' stock...